Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Jan 03, 2024 9:20am
63 Views
Post# 35808428

RE:Votes

RE:Votes
fossi_2002 wrote:
If Oats carefully considers the merger of AEZS and CZO and at least abstains or does not participate in the vote, we have a good chance that the merger in this form will not get the necessary votes.

Why would he want to abstain? It's clear that given the track record of shareholder value destruction at AEZS under Gilles as CEO and as a board member, and even without him is a disaster: by selling CZO at a below liquidation valuation, he needs to vote no to this merger.

It's about time that Gilles gets knocked out for his years of stringing us and OATS group of devoted shareholders to the point that Gilles has essentially given up on CEAPRO by selling it for next to nothing given years of touting PGX as a disruptive delivery system for bioactives. He has failed to execute on all levels. Only management of the new company will benefit from this merger with more years of guaranteed salaries while working remote. Lack of insider ownership shows their interests are not asigned with shareholders thus the 96%  drop in AEZS share price in 3 years and even more than over the decades.
<< Previous
Bullboard Posts
Next >>